AbbVie revenue beats expectations on Humira demand – Reuters
AbbVie Inc beat quarterly revenue estimates and forecast annual profit above expectations on Wednesday due to higher demand for its blockbuster drug Humira as well as newer treatments for psoriasis and rheumatoid arthritis.
